ArticleFrontiers in immunology2025

Multi-scale data reveal a CD24(+) MUCL1(+) tumor subgroup associated with unfavorable prognosis in ER+ breast cancer.

Yingxi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.